Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Journal1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Am J Dis Child1
- Springer Nature eBooks1
Search Results
Sort by
- BookNeha Srivastava, Manish Srivastava, P.K. Mishra, Vijai Kumar Gupta, editors.Springer Nature eBooks.Summary: Converting biomass to biofuels involves hydrolyzing cellulose to sugars using cost-intensive commercial enzymes an expensive step that makes large-scale production economically non-viable. As such, there is a need for low-cost bioprocessing. This book critically evaluates the available bioprocessing technologies for various biofuels, and presents the latest research in the field. It also highlights the recent developments, current challenges and viable alternative approaches to reduce the overall cost of producing biofuels.
Contents:
Chapter 1. Impact of fermentation types on enzymes used for biofuels production
Chapter 2. Downstream Processing; Applications and Recent Updates
Chapter 3. Role of bioreactors in bio-fuel generations
Chapter 4. Bioprocess for Algal Biofuels Production
Chapter 5. Effect of Bioprocess Parameters on Biofuel Production
Chapter 6. Role of substrate to improve biomass to bio fuel production technologies
Chapter 7. Techno-economic analysis of second-generation bio-fuel technologies
Chapter 8. Recent advances in metabolic engineering and synthetic biology for microbial production of isoprenoid-based biofuels: an overview
Chapter 9. Applications of biosensors for metabolic engineering of microorganisms and its impact on biofuel production
Chapter 10. Recent progress in CRISPR-based technologies applications for biofuels production. - ArticleUittenbogaart CH, Isaacson AS, Stanley P, Pennisi AJ, Malekzadeh MH, Ettenger RB, Fine RN.Am J Dis Child. 1978 Aug;132(8):765-7.Aseptic necrosis developed in 11 (6%) of 171 recipients of renal allografts who underwent transplant operations at Childrens Hospital of Los Angeles between February 1967 and August 1977. Pain was the predominant presenting symptom and preceded roentgenographic evidence of aseptic necrosis by as long as seven months. Initial symptoms occurred two months to four years posttransplant. Limited weight bearing and reduction in the dosage of prednisone failed to prevent the progressive destruction of five femoral heads in three patients. Hip replacement led to an amelioration of the symptoms and a resumption of normal activity in each patient. Two patients with involvement of multiple osseous structures have persistent knee and elbow joint pain and effusions, and one of them has required prosthetic replacement of the proximal humerus. No therapy was required for patients with aseptic necrosis of single bones of the hand and foot. There was no statistically significant difference in the total steroid dose received during the first posttransplant year between patients in whom aseptic necrosis developed, and those in whom it did not develop.